Table 4.
Mean oocyst shed per treatment group x 10 4 /gram of feces (Days posttreatment) | |||||
---|---|---|---|---|---|
Group | Treatment day | Day 7 | Day 13 | Day 17 | Day 20 |
Negative control (1A) | 0.06±0.02a | 0.09±0.03a | 0.173±0.07a | 0.14±0.04a | 0.14±0.04a |
| |||||
Amprolium (2B) | 19.01±9.57ab | 357.67±123.45b | 416.83±129.86a | 429.60±129.85ab | 430.00±62.45ab |
| |||||
Positive control (3C) | 34.93±16.28a | 170.20±68.92ab | 432.40±142.79a | 642.40±177.50b | 590.02±96.13b |
| |||||
Diclazuril (4D) | 59.70±12.35ab | 0.12±0.10a | 0.00±0.00a | 0.00±0.00a | 0.00±0.00a |
| |||||
Sulphachloropyrazine (5E) | 149.00±110.39ab | 0.83±0.40a | 2.03±0.83a | 2.03±0.70a | 3.31±0.86a |
| |||||
Trimethoprim-sulphamethoxazole (6F) | 197.17±92.66b | 61.17±10.60a | 230.50±154.30a | 358.00±163.17ab | 231.67±51.4a |
| |||||
p-value | 0.154 | <0.001 | 0.008 | <0.001 | <0.001 |
Values with different superscripts in a column are significantly different at 0.05.